ARCHIVES

Also ASCO to release abstracts to members prior to annual meeting.

This article is from The Cancer Letter archive.

Vol. 30 No. 05 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

Nature Editorial Criticizes NCI PR Spending

March 15, 2013

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel

November 26, 1999

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

January 25, 2008

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012